Medtech company Stryker is set to launch its FDA-cleared Incompass Total Ankle System.
The system is intended for individuals with end-stage ankle arthritis and has a new implant and enhanced instrument platform, according to a Sept. 9 news release from Stryker.
Surgeons can adjust implant configurations in real time and includes 3D-printed porous metal tibial and talar components to promote early bony ingrowth.
The company utilized its orthopedic modeling and analytics tool, as well as more than 80,000 scans to design the implants, the release said.
Stryker received FDA clearance for the Incompass system in June.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.